TG Therapeutics Inc.

NASDAQ: TGTX · Real-Time Price · USD
28.03
0.26 (0.94%)
At close: Aug 15, 2025, 3:12 PM

TG Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
179.89M 92.93M 102.3M 298.89M
Short-Term Investments
131.11M 124.58M 59.37M 15.88M
Long-Term Investments
2.11M n/a 12.4M 35.53M
Other Long-Term Assets
2.07M 2.7M 1.27M 1.26M
Receivables
129.19M 51.09M n/a 1.39M
Inventory
110.46M 39.82M n/a -23.6M
Other Current Assets
15.72M 5.34M 2.36M 2.88M
Total Current Assets
566.36M 317.94M 168.27M 330.96M
Property-Plant & Equipment
7.15M 8.14M 10.82M 11.07M
Goodwill & Intangibles
n/a 799K 799K 799K
Total Long-Term Assets
11.33M 11.64M 25.3M 48.66M
Total Assets
577.69M 329.59M 193.57M 379.63M
Account Payables
58.3M 38.47M 42.02M n/a
Deferred Revenue
12.21M n/a 305K 457K
Short-Term Debt
661K n/a 1.58M 2.41M
Other Current Liabilities
3.17M 13.8M 8.02M 61.53M
Total Current Liabilities
90.68M 53.72M 53.2M 65.38M
Long-Term Debt
244.43M 100.12M 71.14M 66.79M
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
264.65M 115.36M 81.78M 77.09M
Total Liabilities
355.33M 169.09M 134.99M 142.48M
Total Debt
254.38M 110.8M 83.06M 79.05M
Common Stock
156K 151K 146K 143K
Retained Earnings
-1.53B -1.51B -1.53B -1.33B
Comprehensive Income
n/a n/a -0.00 0.00
Shareholders Equity
222.36M 160.5M -1.53B -1.33B
Total Investments
131.91M 124.58M 71.78M 51.41M